Literature DB >> 1699130

Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11.

M A Shipp1, G B Stefano, L D'Adamio, S N Switzer, F D Howard, J Sinisterra, B Scharrer, E L Reinherz.   

Abstract

The antigen CD10 (common acute lymphoblastic leukaemia antigen), which is the zinc metalloprotease, neutral endopeptidase 24.11 (also known as NEP or 'enkephalinase'), is expressed by acute lymphoblastic leukaemias, normal lymphoid progenitors, mature polymorphonuclear leukocytes and certain nonhaematopoietic cells. CD10/NEP hydrolyses several naturally occurring peptides, including the endogenous opioid pentapeptides Met- and Leu-enkephalin. In invertebrate organisms such as the mollusc Mytilus edulis, Met-enkephalin triggers inflammatory responses by inducing morphological changes, directed migration and aggregation of haemocytes. We report here that a structure related to CD10/NEP is expressed by M. edulis haemocytes and that abrogation of CD10/NEP enzymatic activity reduces the amount of Met-enkephalin required for haemocyte activation by five orders of magnitude. Similar results are obtained with CD10+ human polymorphonuclear leukocytes, indicating that CD10/NEP related structures regulate enkephalin-mediated inflammatory responses in organisms whose ancestors diverged approximately 500 million years ago.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699130     DOI: 10.1038/347394a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  28 in total

1.  Degradation of Met-enkephalin by hemolymph peptidases in Mytilus edulis.

Authors:  M K Leung; S Le; S Houston; G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

Review 2.  Invertebrate and vertebrate neuroimmune and autoimmunoregulatory commonalties involving opioid peptides.

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

3.  CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung.

Authors:  M A Shipp; G E Tarr; C Y Chen; S N Switzer; L B Hersh; H Stein; M E Sunday; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 4.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

5.  Acetorphan and diarrhoea.

Authors:  A T Cole; C J Hawkey
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

6.  CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.

Authors:  R K Ganju; M Sunday; D G Tsarwhas; A Card; M A Shipp
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Corticotropin-releasing factor-induced immunosuppression in human and invertebrate immunocytes.

Authors:  E M Smith; T K Hughes; P Cadet; G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

8.  Inhibition of CD10/neutral endopeptidase 24.11 promotes B-cell reconstitution and maturation in vivo.

Authors:  G Salles; H R Rodewald; B S Chin; E L Reinherz; M A Shipp
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  [D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells.

Authors:  G B Stefano; P Melchiorri; L Negri; T K Hughes; B Scharrer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  CD10 expression in urothelial carcinoma of the bladder.

Authors:  Burak Bahadir; Kemal Behzatoglu; Sibel Bektas; Erol R Bozkurt; Sukru O Ozdamar
Journal:  Diagn Pathol       Date:  2009-11-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.